Hangzhou Lingji Pharmaceutical Technology

Hangzhou Lingji Pharmaceutical Technology is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages a proprietary structure-based drug discovery platform to target proteins previously considered undruggable, with a primary focus on oncology and autoimmune disorders. Founded by a team of experienced scientists from global pharmaceutical companies, Lingji aims to address significant unmet medical needs through precision medicine. The company is currently in the pre-clinical stage, advancing a pipeline of novel candidates toward IND-enabling studies.